Literature DB >> 3488021

Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae.

J H Jorgensen, J S Redding, A W Howell.   

Abstract

LY 164846, a new oral cephalosporin, demonstrated very good inhibitory and bactericidal activities against Haemophilus influenzae irrespective of the production of beta-lactamase by the test strains. However, its activity was not markedly superior to that of either Augmentin (amoxicillin plus clavulanate) or cefaclor.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3488021      PMCID： PMC180505          DOI： 10.1128/AAC.29.6.1090

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts.

Authors:  J Campos; S Garcia-Tornel; I Sanfeliu
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

2.  MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.

Authors:  C J Shanholtzer; L R Peterson; M L Mohn; J A Moody; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

3.  Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b.

Authors:  P A Offit; J M Campos; S A Plotkin
Journal:  Pediatrics       Date:  1982-02       Impact factor: 7.124

4.  Ampicillin-resistant Haemophilus influenzae and otitis media.

Authors:  R H Michaels
Journal:  Am J Dis Child       Date:  1981-05

5.  Antimicrobial resistance of Haemophilus species in patients with chronic bronchitis.

Authors:  C A Kauffman; A G Bergman; C S Hertz
Journal:  Am Rev Respir Dis       Date:  1979-12

Review 6.  Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature.

Authors:  P M Mendelman; C A Doroshow; S L Gandy; V Syriopoulou; C P Weigen; A L Smith
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

7.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

8.  Haemophilus influenzae type B resistant to tetracycline isolated from children with meningitis.

Authors:  D Hansman
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

9.  Meningitis due to Haemophilus influenzae type b resistant to both ampicillin and chloramphenicol.

Authors:  J F Kenny; C D Isburg; R H Michaels
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

10.  Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.

Authors:  D A Strandberg; J H Jorgensen; D J Drutz
Journal:  Diagn Microbiol Infect Dis       Date:  1984-09       Impact factor: 2.803
View more
  2 in total

1.  beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.

Authors:  C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.